9 assets in Type 1 Diabetes Mellitus

Therapeutic assets addressing Type 1 Diabetes Mellitus, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Metformin Type 1 Diabetes Mellitus	Heba M. Ismail	P4	A (80)
Liraglutide Type 1 Diabetes Mellitus	Dasman Diabetes Institute	P4	BBB (79)
Tirzepatide Type 1 Diabetes Mellitus	Royal North Shore Hospital	P4	BBB (78)
Semaglutide Type 1 Diabetes Mellitus	Nordsjaellands Hospital	P3	BB (66)
ct-868 Type 1 Diabetes Mellitus	Carmot Therapeutics, Inc.	P2	BB (64)
Ladarixin Type 1 Diabetes Mellitus	Dompé Farmaceutici S.p.A	P2	CC (45)
Dapagliflozin Type 1 Diabetes Mellitus	Dasman Diabetes Institute	N/A	D (30)
nnc0497-0040 Type 1 Diabetes Mellitus	Novo Nordisk A/S	P1	NR ()